Former Surgeon General appointed by President Trump, Jerome Adams, strongly criticized the recent move by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. to cut back on mRNA vaccine investments, which are currently helping combat bird flu and COVID-19.
Adams expressed his concerns on social media Tuesday, stating, “I’ve aimed for an impartial and cautious approach regarding the latest HHS decisions – but honestly, this will endanger lives.”
He further elaborated, “mRNA technology has applications extending well beyond vaccination… and the rapid development of the vaccine is attributed to saving millions of lives.”
On Tuesday, Kennedy revealed that the HHS is curtailing its efforts in mRNA vaccine R&D under the Biomedical Advanced Research and Development Authority (BARDA) by terminating 22 projects worth approximately $500 million.
Kennedy explained on Tuesday that, “After a review of the scientific data and expert consultation, we took action. Findings suggest these vaccines do not sufficiently protect against respiratory illnesses like COVID and the flu. We are redirecting these funds toward safer and more adaptable vaccine technologies that remain effective amidst virus mutations.”
This follows an announcement from HHS stating that an extensive evaluation of mRNA investment efforts, initiated during the COVID-19 crisis, was conducted. The agency plans to phase out pandemic-era vaccine technologies not meeting “current scientific benchmarks” in favor of comprehensive virus vaccines and innovative platforms.
Adams was known as a relatively low-profile member of Trump’s first administration, but he has become a prominent voice speaking out against the public health policies and decisions carried out during the president’s second term.
During the pandemic, Adams at times broke from Trump, such as when the president downplayed the death toll of COVID-19 or suggested injecting bleach to combat infections.
